INM
Inmed Pharmaceuticals Inc
NASDAQ · Pharmaceuticals
$0.94
-0.04 (-4.21%)
Open$0.98
Previous Close$0.98
Day High$0.98
Day Low$0.90
52W High$43.44
52W Low$23.25
Volume—
Avg Volume424.1K
Market Cap2.64M
P/E Ratio15.82
EPS$1.91
SectorPharmaceuticals
Analyst Ratings
Strong Sell
8 analysts
Price Target
+3,478.6% upside
Current
$0.94
$0.94
Target
$33.65
$33.65
$24.21
$33.65 avg
$46.15
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 849.9K | 790.8K | 761.6K |
| Net Income | 151.2K | 172.0K | 136.0K |
| Profit Margin | 17.8% | 21.8% | 17.9% |
| EBITDA | 223.3K | 218.3K | 221.4K |
| Free Cash Flow | 102.9K | 109.5K | 116.5K |
| Rev Growth | +21.7% | +11.4% | +19.5% |
| Debt/Equity | 0.10 | 0.10 | 0.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |